Natural food company Hain Celestial (NASDAQ:HAIN) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 11% year on year to $390.4 million. Its non-GAAP profit of $0.07 per share was 44.5% below analysts’ consensus estimates. Is now the time to buy Hain Celestial? Find out in our full research report. Hain Celestial (HAIN) Q1 CY2025 Highlights: Revenue: $390.4 million vs analyst estimates of $409.4 million (11% year-on-year decline, 4.7% miss) Adjusted EPS: $0.07 vs analyst expectations of $0.13 (44.5% miss) Adjusted EBITDA: $33.62 million vs analyst estimates of $42.35 million (8.6% margin, 20.6% miss) EBITDA guidance for the full year is $125 million at the midpoint, below analyst estimates of $150.1 million Operating Margin: -31%, down from 6.9% in the same quarter last year Free Cash Flow was -$2.28 million, down from $30.24 million in the same quarter last year Organic Revenue fell 5.3% year on year (-3.7% in the same quarter last year) Market Capitalization: $250 million "We are disappointed with our third quarter results, which fell far short of our expectations primarily due to worse-than-expected performance in North America. Despite the shortfall in net sales in the quarter, we are encouraged by a return to organic net sales growth in our international segment and continued progress in reducing net debt,” said Alison Lewis, Interim President and CEO. Company Overview Sold in over 75 countries around the world, Hain Celestial (NASDAQ:HAIN) is a natural and organic food company whose products range from snacks to teas to baby food. Sales Growth Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. With $1.62 billion in revenue over the past 12 months, Hain Celestial is a small consumer staples company, which sometimes brings disadvantages compared to larger competitors benefiting from economies of scale and negotiating leverage with retailers. As you can see below, Hain Celestial’s demand was weak over the last three years. Its sales fell by 5% annually, a poor baseline for our analysis.Hain Celestial Quarterly Revenue This quarter, Hain Celestial missed Wall Street’s estimates and reported a rather uninspiring 11% year-on-year revenue decline, generating $390.4 million of revenue. Looking ahead, sell-side analysts expect revenue to grow 1.4% over the next 12 months. Although this projection suggests its newer products will fuel better top-line performance, it is still below the sector average. Story Continues Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend. Organic Revenue Growth When analyzing revenue growth, we care most about organic revenue growth. This metric captures a business’s performance excluding one-time events such as mergers, acquisitions, and divestitures as well as foreign currency fluctuations. Hain Celestial’s demand has been falling over the last eight quarters, and on average, its organic sales have declined by 4% year on year.Hain Celestial Year-On-Year Organic Revenue Growth In the latest quarter, Hain Celestial’s organic sales fell by 5.3% year on year. This decrease represents a further deceleration from its historical levels. We hope the business can get back on track. Key Takeaways from Hain Celestial’s Q1 Results We struggled to find many positives in these results as it missed across revenue, EPS, and EBITDA. Its full-year EBITDA guidance also fell short of Wall Street’s estimates. Overall, this quarter could have been better. The stock traded down 17.5% to $2.28 immediately after reporting. Hain Celestial’s latest earnings report disappointed. One quarter doesn’t define a company’s quality, so let’s explore whether the stock is a buy at the current price. What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here, it’s free. View Comments
Hain Celestial (NASDAQ:HAIN) Misses Q1 Sales Targets, Stock Drops 17.5%
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...